Boyd’s remarks will highlight key accomplishments from the previous year, as well as outline initiatives that will help solidify UT’s greatest decade in history.
When Moderna wanted to check if its COVID-19 vaccine would work against the new strains emerging in England and South Africa, it again turned to UT Health Science Center researcher Michael Whitt.
“We continue to diligently monitor the situation across the state to make adjustments in the best interest of our students, faculty and staff,” said UT President Randy Boyd.
